Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Group A, C Polysaccharide Meningitis”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Post-approval studies (Phase 4)Study completedNCT01430611
What this trial is testing

Study of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in Children

Who this might be right for
Meningococcal DiseaseMeningitis
Sanofi Pasteur, a Sanofi Company 666
Large-scale testing (Phase 3)Study completedNCT02003313
What this trial is testing

Immunogenicity and Safety of Group A, C, Y and W135 Meningococcal Polysaccharide Vaccine

Who this might be right for
Meningitis
Beijing Minhai Biotechnology Co., Ltd 1,260
Not applicableStudy completedNCT00254995
What this trial is testing

Descriptive, Post-marketing, Surveillance Safety Study of Menactra Vaccine

Who this might be right for
MeningitisMeningococcal Disease
Sanofi Pasteur, a Sanofi Company 62,626
Testing effectiveness (Phase 2)Study completedNCT00700713
What this trial is testing

Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26

Who this might be right for
MeningitisMeningococcemia
Sanofi Pasteur, a Sanofi Company 181
Early research (Phase 1)Study completedNCT01482052
What this trial is testing

Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 60
Large-scale testing (Phase 3)Study completedNCT00483574
What this trial is testing

Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers

Who this might be right for
Meningococcal MeningitisMeaslesMumps+2 more
Sanofi Pasteur, a Sanofi Company 1,378
Large-scale testing (Phase 3)Study completedNCT01890759
What this trial is testing

Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 300
Large-scale testing (Phase 3)Study completedNCT01580033
What this trial is testing

Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine

Who this might be right for
MeningitisInfluenza
Jiangsu Province Centers for Disease Control and Prevention 900
Large-scale testing (Phase 3)UnknownNCT04689191
What this trial is testing

A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine

Who this might be right for
Meningitis, Meningococcal
Wei Cun 1,280
Large-scale testing (Phase 3)Study completedNCT01428908
What this trial is testing

Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children

Who this might be right for
Group A, C Polysaccharide MeningitisType b Haemophilus Influenza
Jiangsu Province Centers for Disease Control and Prevention 2,394
Large-scale testing (Phase 3)Study completedNCT01519713
What this trial is testing

Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 200
Large-scale testing (Phase 3)Study completedNCT01086969
What this trial is testing

Meningococcal Vaccine, Menactra® in Healthy Subjects in India

Who this might be right for
Meningococcal InfectionMeningitis
Sanofi 300
Large-scale testing (Phase 3)Study completedNCT01359449
What this trial is testing

Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 123
Large-scale testing (Phase 3)Study completedNCT00384397
What this trial is testing

2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers

Who this might be right for
Meningococcal MeningitisMeaslesMumps+2 more
Sanofi Pasteur, a Sanofi Company 1,128
Testing effectiveness (Phase 2)Study completedNCT00874549
What this trial is testing

Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years

Who this might be right for
Meningococcal InfectionsMeningococcal Meningitis
Sanofi Pasteur, a Sanofi Company 216
Not applicableStudy completedNCT02699840
What this trial is testing

Observational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian Federation

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 100
Testing effectiveness (Phase 2)Study completedNCT02640404
What this trial is testing

Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 224
Post-approval studies (Phase 4)Study completedNCT01270503
What this trial is testing

Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the Philippines

Who this might be right for
MeningitisMeningococcal Disease
Sanofi Pasteur, a Sanofi Company 538
Large-scale testing (Phase 3)Study completedNCT00617760
What this trial is testing

Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®)

Who this might be right for
Neisseria Meningitidis (Bacterial Meningitis)Invasive Pneumococcal Disease (IPD)
Pfizer 330
Post-approval studies (Phase 4)Study completedNCT02864927
What this trial is testing

Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 1,311
Load More Results